These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
652 related articles for article (PubMed ID: 34015982)
21. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis. Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W Front Immunol; 2022; 13():1058884. PubMed ID: 36532040 [TBL] [Abstract][Full Text] [Related]
22. The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection. Lécuyer D; Nardacci R; Tannous D; Gutierrez-Mateyron E; Deva Nathan A; Subra F; Di Primio C; Quaranta P; Petit V; Richetta C; Mostefa-Kara A; Del Nonno F; Falasca L; Marlin R; Maisonnasse P; Delahousse J; Pascaud J; Deprez E; Naigeon M; Chaput N; Paci A; Saada V; Ghez D; Mariette X; Costa M; Pistello M; Allouch A; Delelis O; Piacentini M; Le Grand R; Perfettini JL Front Immunol; 2023; 14():1270081. PubMed ID: 37920468 [TBL] [Abstract][Full Text] [Related]
23. Cyanidin-3-O-glucoside and Peonidin-3-O-glucoside-Rich Fraction of Black Rice Germ and Bran Suppresses Inflammatory Responses from SARS-CoV-2 Spike Glycoprotein S1-Induction In Vitro in A549 Lung Cells and THP-1 Macrophages via Inhibition of the NLRP3 Inflammasome Pathway. Semmarath W; Mapoung S; Umsumarng S; Arjsri P; Srisawad K; Thippraphan P; Yodkeeree S; Dejkriengkraikul P Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807916 [TBL] [Abstract][Full Text] [Related]
24. miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19. Houshmandfar S; Saeedi-Boroujeni A; Rashno M; Khodadadi A; Mahmoudian-Sani MR Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2187-2195. PubMed ID: 34590186 [TBL] [Abstract][Full Text] [Related]
25. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2. Cheon SY; Koo BN Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360684 [TBL] [Abstract][Full Text] [Related]
26. Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention. Zhang J; Ma X; Liu F; Zhang D; Ling J; Zhu Z; Chen Y; Yang P; Yang Y; Liu X; Zhang J; Liu J; Yu P Front Immunol; 2023; 14():1203389. PubMed ID: 37868953 [TBL] [Abstract][Full Text] [Related]
27. Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial. Saeedi-Boroujeni A; Nashibi R; Ghadiri AA; Nakajima M; Salmanzadeh S; Mahmoudian-Sani MR; Hanafi MG; Sharhani A; Khodadadi A Arch Med Res; 2022 Jun; 53(4):368-377. PubMed ID: 35339280 [TBL] [Abstract][Full Text] [Related]
28. Targeting the NLRP3 Inflammasome in Severe COVID-19. Freeman TL; Swartz TH Front Immunol; 2020; 11():1518. PubMed ID: 32655582 [TBL] [Abstract][Full Text] [Related]
29. The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases. Cama VF; Marín-Prida J; Acosta-Rivero N; Acosta EF; Díaz LO; Casadesús AV; Fernández-Marrero B; Gilva-Rodríguez N; Cremata-García D; Cervantes-Llanos M; Piniella-Matamoros B; Sánchez D; Del Rosario-Cruz L; Borrajero I; Díaz A; González Y; Pentón-Arias E; Montero-González T; Guillen-Nieto G; Pentón-Rol G J Neuroimmunol; 2021 Dec; 361():577728. PubMed ID: 34619427 [TBL] [Abstract][Full Text] [Related]
30. Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation. Zhang J; Wang C; Wang H; Li X; Xu J; Yu K Int Immunopharmacol; 2021 Jun; 95():107529. PubMed ID: 33744777 [TBL] [Abstract][Full Text] [Related]
31. Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19. Manayi A; Nabavi SM; Khayatkashani M; Habtemariam S; Khayat Kashani HR Mol Biol Rep; 2021 Dec; 48(12):8221-8225. PubMed ID: 34655016 [TBL] [Abstract][Full Text] [Related]
32. Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies. He Q; Hu D; Zheng F; Chen W; Hu K; Liu J; Yao C; Li H; Wei Y Viruses; 2024 Jan; 16(2):. PubMed ID: 38399989 [TBL] [Abstract][Full Text] [Related]
33. Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells. Sur S; Steele R; Isbell TS; Ray R; Ray RB mBio; 2022 Jun; 13(3):e0095122. PubMed ID: 35587188 [TBL] [Abstract][Full Text] [Related]
37. Hesperetin from Root Extract of Arjsri P; Srisawad K; Mapoung S; Semmarath W; Thippraphan P; Umsumarng S; Yodkeeree S; Dejkriengkraikul P Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142258 [TBL] [Abstract][Full Text] [Related]
38. The hidden role of NLRP3 inflammasome in obesity-related COVID-19 exacerbations: Lessons for drug repurposing. Bertocchi I; Foglietta F; Collotta D; Eva C; Brancaleone V; Thiemermann C; Collino M Br J Pharmacol; 2020 Nov; 177(21):4921-4930. PubMed ID: 32776354 [TBL] [Abstract][Full Text] [Related]
39. The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target? Pacheco PAF; Faria RX Scand J Immunol; 2021 Feb; 93(2):e12960. PubMed ID: 32797724 [TBL] [Abstract][Full Text] [Related]
40. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone. Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]